ReviewInnere Medizin (Heidelberg, Germany)2025
[Nephrotic syndrome].
Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Urine-Derived Stem Cells: Challenges in Isolation, Biological Identity, and Therapeutic Potential in CKD-Associated Fibrosis.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nephrotic syndrome (NS) is characterized by proteinuria > 3.5 g/day, hypoalbuminemia, peripheral edema, and hyperlipidemia. Common primary causes of NS are podocytopathies, such as minimal change nephropathy, focal segmental glomerulosclerosis, and membranous nephropathy. In a subset of patients with primary NS autoantibodies against podocyte antigens can be detected. Diabetes mellitus, amyloidosis, systemic lupus erythematosus, malignancies, infections, and medications are some of the numerous secondary causes of NS. Beside searching for secondary causes, a kidney biopsy is usually performed to define the entity of NS. Complications of NS include venous thrombosis, infections, and the development of acute or chronic kidney disease. Sodium restriction, loop diuretics, statins, possibly anticoagulation, and antiproteinuric therapy are important measure for supportive therapy in NS. In addition, immunosuppressive treatment is often required.
Indexed as
Identifiers
40760331What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.